Search

everythinglearnresearchcommunity

for

Search:↓

The new delivery system could improve pain and inflammation relief in gout.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

A man with KID syndrome developed a rare cancer in a long-term skin infection.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Agmatine may help reduce seizures linked to hormone changes in female rats.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Ivermectin and sulfur effectively treated the cat's scabies and sporotrichosis in 14 days.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Monitor methotrexate side effects, research cannabis treatments, and use mycophenolate mofetil for lupus nephritis.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Certain alkaloids could help create new coronavirus drugs.

High-dose iron therapy improves anemia without affecting IBD treatment.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Vitamin D3-coated nanoparticles effectively deliver caffeine for alopecia treatment with minimal side effects.

Cetuximab can cause eyelash growth, which is rare but manageable.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Sulfur-containing radioprotectors can protect hair from X-ray damage if given before exposure but worsen damage if given after.